PREDICTORS OF MANUFACTURING (MFG) SUCCESS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IN NON-HODGKIN LYMPHOMA

被引：0
|
作者：
Davis, M. M. [1 ,2 ]
Fesnak, A. [1 ,2 ]
Leskowitz, R. M. [1 ,2 ]
McKee, J. S. [1 ,2 ]
Ohayon, Y. [1 ,2 ]
Corl, C. M. [1 ,2 ]
Malykhin, A. [1 ,2 ]
Fraietta, J. A. [1 ,2 ]
Melenhorst, J. Joseph [1 ,2 ]
June, C. [1 ,2 ]
Schuster, S. [3 ]
Levine, B. L. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2017年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
180
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [21] Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche Reply
    Roeland, Eric J.
    Loprinzi, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3819 - +
  • [22] Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma
    Hairuo Wen
    Xiaoyan Lou
    Zhe Qu
    Chao Qin
    Hua Jiang
    Ying Yang
    Liqing Kang
    Xingchao Geng
    Lei Yu
    Ying Huang
    Discover Oncology, 13
  • [23] Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma
    Wen, Hairuo
    Lou, Xiaoyan
    Qu, Zhe
    Qin, Chao
    Jiang, Hua
    Yang, Ying
    Kang, Liqing
    Geng, Xingchao
    Yu, Lei
    Huang, Ying
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [24] Cellular Kinetics of CD19 Chimeric Antigen Receptor T Cells in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Li, Caixia
    Zhang, Changfeng
    Zhang, Ying
    Lou, Xiaoyan
    Zhang, Jinfang
    Chen, Jia
    Chen, Xiaochen
    Kang, Liqing
    Zhou, Jin
    Zong, Xiangping
    Yang, Zhen
    Li, Jiaqi
    Qi, Wei
    Yu, Lei
    Wu, Depei
    BLOOD, 2019, 134
  • [25] CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and NonHodgkin Lymphoma in Pediatric Patients
    Hucks, George E., Jr.
    Savoldo, Barbara
    Dotti, Gianpietro
    Cheng, Catherine Joyce Arago
    Babinec, Caroline
    Kasow, Kimberly A.
    Winstead, Michael
    Patel, Arpita
    Presler, Cammie
    Grover, Natalie S.
    Morrison, J. Kaitlin
    Beaven, Anne W.
    Riches, Marcie L.
    Shea, Thomas C.
    Serody, Jonathan S.
    BLOOD, 2021, 138
  • [26] Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma
    Ahrendsen, Jared T.
    Sehgal, Kartik
    Sarangi, Sasmit
    Uhlmann, Erik J.
    Varma, Hemant
    Arnason, Jon
    Avigan, David
    JOURNAL OF HEMATOLOGY, 2021, 10 (05) : 212 - 216
  • [27] Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
    Arscott, W. T.
    Miller, D.
    Jones, J. A.
    Winchell, N.
    Schuster, S.
    Plastaras, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S122 - S122
  • [28] Chimeric antigen receptor T cells targeting the lambda light chain of human immunoglobulin as a viable target for B cell non-Hodgkin lymphoma
    Ranganathan, Raghuveer
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients
    Su, Tong
    Ying, Zhitao
    Lu, Xin-An
    He, Ting
    Song, Yuqin
    Wang, Xiaopei
    Ping, Lingyan
    Xie, Yan
    Tu, Meifeng
    Liu, Guanghua
    Qi, Feifei
    Ding, Yanping
    Jing, Hongmei
    Zhu, Jun
    CRYOBIOLOGY, 2020, 96 : 106 - 113
  • [30] Relapsed/Refractory Non-Hodgkin Lymphoma: Engineering T-Cells to Express Chimeric Antigen Receptors (CARs), a Salvage?
    Kanwal, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
12345